Jennifer S Smith

Summary

Affiliation: International Agency for Research on Cancer
Country: France

Publications

  1. ncbi Prevalence and risk factors for herpes simplex virus type 2 infection among middle-age women in Brazil and the Philippines
    J S Smith
    International Agency for Research on Cancer, Lyon, France
    Sex Transm Dis 28:187-94. 2001
  2. ncbi Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer
    Jennifer S Smith
    Unit of Field and Intervention Studies, International Agency for Research on Cancer IARC, Lyon, France
    J Natl Cancer Inst 94:1604-13. 2002
  3. ncbi Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review
    Jennifer S Smith
    International Agency for Research on Cancer IARC, Unit of Field and Intervention Studies, 69372 Lyon, France
    J Infect Dis 186:S3-28. 2002
  4. ncbi Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines
    Jennifer S Smith
    International Agency for Research on Cancer, F 69372 Lyon Cedex 08, France
    J Infect Dis 185:324-31. 2002
  5. ncbi Adeno-associated virus seropositivity and HPV-induced cervical cancer in Spain and Colombia
    J Smith
    International Agency for Research on Cancer, Lyon, France
    Int J Cancer 94:520-6. 2001
  6. ncbi Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study
    Jennifer S Smith
    International Agency for Research on Cancer, Lyon, France
    Int J Cancer 111:431-9. 2004
  7. ncbi Sexual behavior, condom use, and human papillomavirus: pooled analysis of the IARC human papillomavirus prevalence surveys
    Salvatore Vaccarella
    International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
    Cancer Epidemiol Biomarkers Prev 15:326-33. 2006
  8. ncbi Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study
    Nubia Munoz
    Unit of Field and Intervention Studies, International Agency for Research on Cancer, 150 cours Albert Thomas, F 69372, Cedex 08, Lyon, France
    Lancet 359:1093-101. 2002
  9. ncbi Cervical infection with Chlamydia trachomatis and Neisseria gonorrhoeae in women from ten areas in four continents. A cross-sectional study
    Silvia Franceschi
    International Agency for Research on Cancer, Lyon, France
    Sex Transm Dis 34:563-9. 2007
  10. ncbi Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer
    Gary M Clifford
    IARC, 150 cours Albert Thomas, F 69372 Lyon Cedex 08, France
    Cancer Epidemiol Biomarkers Prev 14:1157-64. 2005

Collaborators

Detail Information

Publications45

  1. ncbi Prevalence and risk factors for herpes simplex virus type 2 infection among middle-age women in Brazil and the Philippines
    J S Smith
    International Agency for Research on Cancer, Lyon, France
    Sex Transm Dis 28:187-94. 2001
    ..Data comparing type-specific herpes simplex virus type 2 (HSV-2) seroprevalence and risk factors between comparable populations are largely unavailable, particularly from less-developed countries...
  2. ncbi Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer
    Jennifer S Smith
    Unit of Field and Intervention Studies, International Agency for Research on Cancer IARC, Lyon, France
    J Natl Cancer Inst 94:1604-13. 2002
    ..We performed a pooled analysis of seven case-control studies to examine the effect of one possible HPV cofactor, herpes simplex virus-2 (HSV-2) infection, in the etiology of invasive cervical cancer...
  3. ncbi Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review
    Jennifer S Smith
    International Agency for Research on Cancer IARC, Unit of Field and Intervention Studies, 69372 Lyon, France
    J Infect Dis 186:S3-28. 2002
    ..HSV-1 infection is acquired during childhood and adolescence and is markedly more widespread than HSV-2 infection. Further studies are needed in many geographic areas...
  4. ncbi Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines
    Jennifer S Smith
    International Agency for Research on Cancer, F 69372 Lyon Cedex 08, France
    J Infect Dis 185:324-31. 2002
    ..C. trachomatis infection was found to be a possible cofactor of HPV in the etiology of squamous cervical cancer, and its effect may be mediated by chronic inflammation...
  5. ncbi Adeno-associated virus seropositivity and HPV-induced cervical cancer in Spain and Colombia
    J Smith
    International Agency for Research on Cancer, Lyon, France
    Int J Cancer 94:520-6. 2001
    ....
  6. ncbi Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study
    Jennifer S Smith
    International Agency for Research on Cancer, Lyon, France
    Int J Cancer 111:431-9. 2004
    ..0; 95% CI = 0.53-1.9) in HPV DNA-positive women. An association of C. trachomatis with squamous cell ICC was found among all cases and control women with or without adjustment for HPV...
  7. ncbi Sexual behavior, condom use, and human papillomavirus: pooled analysis of the IARC human papillomavirus prevalence surveys
    Salvatore Vaccarella
    International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
    Cancer Epidemiol Biomarkers Prev 15:326-33. 2006
    ..Our study showed an effect of both women's and their husbands' sexual behavior on HPV positivity. Furthermore, it suggests some differences in the pattern of the association between sexual behavior and different HPV types...
  8. ncbi Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study
    Nubia Munoz
    Unit of Field and Intervention Studies, International Agency for Research on Cancer, 150 cours Albert Thomas, F 69372, Cedex 08, Lyon, France
    Lancet 359:1093-101. 2002
    ..To assess the role of reproductive factors in the progression from HPV infection to cancer, we did a pooled analysis including only HPV-positive women...
  9. ncbi Cervical infection with Chlamydia trachomatis and Neisseria gonorrhoeae in women from ten areas in four continents. A cross-sectional study
    Silvia Franceschi
    International Agency for Research on Cancer, Lyon, France
    Sex Transm Dis 34:563-9. 2007
    ..Better information on the prevalence of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infection is needed in many world areas...
  10. ncbi Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer
    Gary M Clifford
    IARC, 150 cours Albert Thomas, F 69372 Lyon Cedex 08, France
    Cancer Epidemiol Biomarkers Prev 14:1157-64. 2005
    ..Some regional differences in the relative importance of HPV genotypes in LSIL were noted...
  11. ncbi HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy
    Hugo De Vuyst
    Department of Obstetrics and Gynaecology, Ghent University, Belgium
    Eur J Cancer Prev 17:545-54. 2008
    ..Therefore, it remains important to closely monitor HPV-related disease in women with HIV who are receiving HAART, particularly in regions of the world where cervical screening is not available routinely...
  12. ncbi Cervical cancer and use of hormonal contraceptives: a systematic review
    Jennifer S Smith
    International Agency for Research on Cancer, Lyon, France
    Lancet 361:1159-67. 2003
    ..Human papillomavirus (HPV) is believed to be the most important cause of cervical cancer. Recent studies suggest that long duration use of oral contraceptives increases the risk of cervical cancer in HPV positive women...
  13. pmc Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis
    Jill Koshiol
    Cancer Prevention Fellowship Program, Division of Cancer Prevention, National Cancer Institute, Bethesda, MD 20892 7236, USA
    Am J Epidemiol 168:123-37. 2008
    ..Precise definition and standardization of HPV testing, sampling procedure, and test interval are needed for reliable clinical testing. These findings validate HPV persistence as a clinical marker and endpoint...
  14. doi Age-specific prevalence of infection with human papillomavirus in females: a global review
    Jennifer S Smith
    Department of Epidemiology, University of North Carolina, Chapel Hill, North Carolina 27599, USA
    J Adolesc Health 43:S5-25, S25.e1-41. 2008
    ..Global data on age-specific prevalence of human papillomavirus (HPV) infection overall, and for high-risk HPV types 16 and 18, are essential for the future implementation of HPV prophylactic vaccines for cervical cancer prevention...
  15. ncbi Smoking and time to clearance of human papillomavirus infection in HIV-seropositive and HIV-seronegative women
    Jill Koshiol
    Department of Epidemiology, School of Public Health, University of North Carolina at Chapel Hill, USA
    Am J Epidemiol 164:176-83. 2006
    ..93, 95% CI: 0.68, 1.26) women. HPV clearance did not appear to vary by amount or duration of smoking. Smoking did not modify overall clearance but was associated with lower high-risk HPV clearance in HIV-seronegative women...
  16. ncbi [The prevalence of high-risk HPV infection in pregnant women from Morelos, México]
    Carlos Hernández-Girón
    Centro de Investigaciones en Salud Poblacional, Instituto Nacional de Salud Publica, Cuernavaca, Morelos, Mexico
    Salud Publica Mex 47:423-9. 2005
    ..This association, however, has not been firmly established. This study seeks to determine the prevalence of oncogenic HPV infecton in a sample of pregnant Mexican women and its possible risk factors...
  17. ncbi Descriptive evidence that risk profiles for cervical intraepithelial neoplasia 1, 2, and 3 are unique
    Suzanne Belinson
    Department of Preventive Medicine, Northwestern University, Chicago, IL 60622, USA
    Cancer Epidemiol Biomarkers Prev 17:2350-5. 2008
    ..This study aimed to estimate if risk factor profiles for histologically confirmed cervical intraepithelial neoplasia (CIN) 2 lesions differ from those for CIN 1 or 3...
  18. ncbi Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update
    Jennifer S Smith
    Department of Epidemiology, University of North Carolina Chapel Hill, Chapel Hill, NC 27599 7435, USA
    Int J Cancer 121:621-32. 2007
    ..Data on HPV-typed ICC and HSIL cases were particularly scarce from large regions of Africa and Central Asia...
  19. doi Lack of association between serum antibodies of Chlamydia pneumoniae infection and the risk of lung cancer
    Jennifer S Smith
    Int J Cancer 123:2469-71. 2008
  20. pmc Human papillomavirus detection by penile site in young men from Kenya
    Jennifer S Smith
    Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA
    Sex Transm Dis 34:928-34. 2007
    ..Limited data are available on whether sampling from the penile shaft or urethra increases detection of penile HPV infection in men beyond that found in the glans and coronal sulcus...
  21. ncbi Type-specific seroprevalence of herpes simplex virus type 2 and associated risk factors in middle-aged women from 6 countries: the IARC multicentric study
    Padmaja Patnaik
    Department of Epidemiology, CB 7435, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 7435, USA
    Sex Transm Dis 34:1019-24. 2007
    ..To determine type-specific seroprevalence of herpes simplex viruses (HSV-1 and HSV-2) and HSV-2 risk factors...
  22. pmc Herpes simplex virus 2 infection in women attending an antenatal clinic in Fuzhou, China
    Xiang Sheng Chen
    National Center for STD Control, Nanjing, China
    Sex Transm Infect 83:369-70. 2007
    ..Consequently, we conducted a survey to determine type specific seroprevalence of HSV-2 and associated risk factors in Fuzhou City, eastern China...
  23. ncbi Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention
    Xavier Castellsague
    Institut d Investigacio Biomedica de Bellvitge, Cancer Epidemiology and Registration Unit, Institut Català d Oncologia L Hospitalet de Llobregat, Barcelona, Spain
    J Natl Cancer Inst 98:303-15. 2006
    ..The extent to which human papillomavirus (HPV) infection and cofactors may explain this differential trend is unclear...
  24. ncbi [Seroprevalence of type 2 herpes simplex virus infection in 3 population groups of Mexico City]
    Carlos J Conde-Gonzalez
    Dirección de Microbiología, Centro De Investigacion sobre Enfermedades Infecciosas, Instituto Nacional de Salud Publica, Avenida Universidad 655, Colonia Santa Maria Ahuacatitlan, 62508 Cuernavaca, Morelos, Mexico
    Salud Publica Mex 45:S608-16. 2003
    ..To determine the seroprevalence of type 2 herpes simplex virus (HSV-2) infection and risk factors in three female population groups in Mexico City...
  25. ncbi Prevalence of human papillomavirus infection in women in Busan, South Korea
    Hai Rim Shin
    Division of Cancer Epidemiology and Control, National Cancer Center Research Institute, Goyang, Korea
    Int J Cancer 103:413-21. 2003
    ..Among 103 virgins, 4.9% had anti-VLPs (1/73 among those aged 24 years or less)...
  26. ncbi Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners
    Xavier Castellsague
    Servei d Epidemiologia i Registre del Cancer, Institut Catala d Oncologia, Hospitalet de Llobregat, Barcelona, Spain
    N Engl J Med 346:1105-12. 2002
    ..It is uncertain whether male circumcision reduces the risks of penile human papillomavirus (HPV) infection in the man and of cervical cancer in his female partner...
  27. ncbi Population-based human papillomavirus prevalence in Lampang and Songkla, Thailand
    Sukhon Sukvirach
    Research Division, National Cancer Institute, Bangkok, Thailand
    J Infect Dis 187:1246-56. 2003
    ..2%) than among women from Songkla (10.9%). Major risk factors for cervical HPV DNA were age <35 years, HSV-2 seropositivity, and having a husband with extramarital sexual partners...
  28. ncbi Chlamydia trachomatis and Human papillomavirus infections in cervical disease in Argentine women
    Carlos D Golijow
    Centro de Investigaciones en Genética Básica y Aplicada CIGEBA, Facultad de Ciencias Veterinarias, UNLP Calle 60 y 118 s n, B1900AVW, La Plata, Argentina
    Gynecol Oncol 96:181-6. 2005
    ..To examine the prevalence of Human papillomavirus and Chlamydia trachomatis DNA in cervical samples among women with normal and abnormal cervical cytology from La Plata, Argentina...
  29. ncbi Human papillomavirus DNA detection and typing in male urine samples from a high-risk population from Argentina
    Carlos D Golijow
    Centro de Investigaciones en Genética Básica y Aplicada CIGEBA, Facultad de Ciencias Veterinarias, Universidad Nacional de La Plata, Calle 60 y 118 S N, B1900AVW, La Plata, Argentina
    J Virol Methods 124:217-20. 2005
    ..The method described below provides a tool for detection and typing of HPV-DNA using samples obtained by non-invasive techniques and thus easy to obtain...
  30. ncbi Chlamydia trachomatis infection in female partners of circumcised and uncircumcised adult men
    Xavier Castellsague
    Cancer Epidemiology and Registration Unit, Institut d Investigacio Biomedica de Bellvitge, Institut Catala d Oncologia, L Hospitalet de Llobregat, Barcelona, Spain
    Am J Epidemiol 162:907-16. 2005
    ..These findings suggest that male circumcision could reduce the risk of C. trachomatis infection in female sexual partners...
  31. ncbi High-risk human papillomavirus detection and related risk factors among pregnant and nonpregnant women in Mexico
    Carlos Hernández-Girón
    Centro de Investigaciones en Salud Poblacional, INSP, Cuernavaca, Mexico
    Sex Transm Dis 32:613-8. 2005
    ..We also investigated the relationship of HPV DNA positivity with socioeconomic, gynecologic, and obstetric risk factors...
  32. ncbi Human papillomavirus infection among women in South and North Vietnam
    Thi Hoang Anh Pham
    Benh Vien K, National Cancer Institute, Hanoi, Vietnam
    Int J Cancer 104:213-20. 2003
    ..Women in Hanoi showed the lowest HPV prevalence ever reported so far, suggesting that HPV has not spread widely in this population. As expected, HPV prevalence in a population seemed to be closely correlated with ICC incidence rates...
  33. pmc Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies
    Julius Atashili
    Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 7435, USA
    AIDS 22:1493-501. 2008
    ..To assess and summarize the published literature on the extent to which bacterial vaginosis may increase the risk of HIV acquisition...
  34. doi Issues in human papillomavirus vaccination in adolescents
    Anna Barbara Moscicki
    J Adolesc Health 43:S1-4. 2008
  35. doi Potential barriers to HPV vaccine provision among medical practices in an area with high rates of cervical cancer
    Katie M Keating
    School of Public Health, University of North Carolina, Chapel Hill, North Carolina 27516, USA
    J Adolesc Health 43:S61-7. 2008
    ..We provide an overview of potential barriers to provision of HPV vaccine and empirical data on the concerns of medical practices that may inhibit HPV vaccine provision...
  36. doi Age considerations when vaccinating against HPV
    Thomas C Wright
    Columbia University, New York, New York 10032, USA
    Gynecol Oncol 109:S40-7. 2008
    ..This review discusses the various considerations that should be addressed when making recommendations of who should be vaccinated against HPV...
  37. doi Initial lessons learned in HPV vaccination
    Thomas J Herzog
    Columbia University, College of Physicians and Surgeons, Department of Obstetrics and Gynecology, 161 Fort Washington Avenue, 8th Floor New York, NY 10032, USA
    Gynecol Oncol 109:S4-11. 2008
    ..This article also examines the impact of the HPV vaccination awareness campaign on media and public policy dynamics...
  38. ncbi Effect of topically applied resveratrol on cutaneous herpes simplex virus infections in hairless mice
    John J Docherty
    Department of Microbiology Immunology, Northeastern Ohio Universities, College of Medicine, PO Box 95, State Route 44, Rootstown, OH 44272, USA
    Antiviral Res 61:19-26. 2004
    ..These studies demonstrate that topically applied resveratrol inhibits HSV lesion formation in the skin of mice...
  39. doi The disparity of cervical cancer in diverse populations
    Levi S Downs
    University of Minnesota, Dept of OB GYN and Women s Health, 420 Delaware Street, 8395 SE, MMC 395 Mayo, Minneapolis, MN 55455, USA
    Gynecol Oncol 109:S22-30. 2008
    ..Strategies to reduce cervical cancer disparities need to be employed in order to reverse these trends...
  40. ncbi HPV vaccine acceptability in a rural Southern area
    Karah I Fazekas
    School of Public Health, University of North Carolina, Chapel Hill, North Carolina 27599, USA
    J Womens Health (Larchmt) 17:539-48. 2008
    ..Although cervical cancer rates in the United States are highest in Southern and rural areas, research on human papillomavirus (HPV) vaccine acceptability has focused on other geographic areas...
  41. ncbi Influence of parent characteristics and disease outcome framing on HPV vaccine acceptability among rural, Southern women
    Nina R Sperber
    School of Public Health, Department of Health Behavior and Health Education, University of North Carolina, Chapel Hill, NC 27599 7400, USA
    Cancer Causes Control 19:115-8. 2008
    ..This study explored the impact of framing the vaccine's benefits, with respect to the disease outcome being prevented, on women's HPV vaccination intentions for themselves and for an adolescent daughter...
  42. ncbi Correlates of national HIV seroprevalence: an ecologic analysis of 122 developing countries
    Paul K Drain
    School of Medicine, University of Washington, Seattle, WA, USA
    J Acquir Immune Defic Syndr 35:407-20. 2004
    ..Ecologic analyses of social and developmental correlates of country-level HIV seroprevalence may suggest strategies for combating the HIV/AIDS epidemic...
  43. ncbi Factors underlying disparities in cervical cancer incidence, screening, and treatment in the United States
    Aletha Y Akers
    Robert Wood Johnson Clinical Scholars Program, University of North Carolina, Chapel Hill, North Carolina, USA
    Curr Probl Cancer 31:157-81. 2007
  44. ncbi Time to clearance of human papillomavirus infection by type and human immunodeficiency virus serostatus
    Jill E Koshiol
    Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA
    Int J Cancer 119:1623-9. 2006
    ..57 (95% CI: 0.22-1.45) for HIV-positive and -negative women, respectively. HPV types within the high-risk category had low estimated clearance rates relative to low-risk types, but HRs were not substantially modified by HIV serostatus...
  45. doi The current and future role of screening in the era of HPV vaccination
    Evan Myers
    Division of Clinical and Epidemiological Research, Department of Obstetrics and Gynecology, DUMC 3279, 244 Baker House, Duke University Medical Center, Durham, NC 27710, USA
    Gynecol Oncol 109:S31-9. 2008
    ....